Literature DB >> 11794717

Autoregulatory cerebral vasodilation occurs during orthostatic hypotension in patients with primary autonomic failure.

D R Horowitz1, H Kaufmann.   

Abstract

It is unclear whether patients with autonomic failure autoregulate cerebral blood flow during hypotension. The objective in this study was to examine cerebral autoregulatory capacity in patients with autonomic failure by studying changes in middle cerebral artery blood flow velocity using transcranial Doppler ultrasonography before, during, and after tilt-induced hypotension. Nine patients with primary autonomic failure were evaluated. Mean arterial pressure and middle cerebral artery blood flow velocity were simultaneously recorded while the patients were in the supine position, during 60 degrees head-up tilt, and after they were returned to the horizontal position. The results were as follows: during tilt-induced hypotension, mean arterial pressure decreased significantly more than middle cerebral artery mean blood flow velocity (58% versus 36%, p <0.0002). After return to the horizontal position, mean arterial pressure returned to baseline, and middle cerebral artery blood flow velocity transiently increased above pretilt value (p <0.02). It is concluded that cerebral autoregulatory vasodilation occurs in patients with autonomic failure. This was demonstrated by a more pronounced decline in mean arterial pressure than in middle cerebral artery blood flow velocity during hypotension and by a transient increase in middle cerebral artery blood flow velocity (ie, hyperemic response) after blood pressure was restored.

Entities:  

Mesh:

Year:  2001        PMID: 11794717     DOI: 10.1007/bf02292768

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  29 in total

1.  Effect of PCO2 changes induced by head-upright tilt on transcranial Doppler recordings.

Authors:  S Cencetti; G Bandinelli; A Lagi
Journal:  Stroke       Date:  1997-06       Impact factor: 7.914

2.  Cerebrovascular and cardiovascular responses to graded tilt in patients with autonomic failure.

Authors:  R L Bondar; P T Dunphy; P Moradshahi; M S Kassam; A P Blaber; F Stein; R Freeman
Journal:  Stroke       Date:  1997-09       Impact factor: 7.914

3.  Variations in middle cerebral artery blood flow investigated with noninvasive transcranial blood velocity measurements.

Authors:  K F Lindegaard; T Lundar; J Wiberg; D Sjøberg; R Aaslid; H Nornes
Journal:  Stroke       Date:  1987 Nov-Dec       Impact factor: 7.914

4.  The sympathetic nervous system and the regulation of cerebral blood flow in man.

Authors:  E Skinhoj
Journal:  Stroke       Date:  1972 Nov-Dec       Impact factor: 7.914

Review 5.  Cerebral autoregulation.

Authors:  O B Paulson; S Strandgaard; L Edvinsson
Journal:  Cerebrovasc Brain Metab Rev       Date:  1990

6.  Autoregulation of cerebral blood flow: influence of the arterial blood pressure on the blood flow through the cerebral cortex.

Authors:  A M Harper
Journal:  J Neurol Neurosurg Psychiatry       Date:  1966-10       Impact factor: 10.154

7.  Orthostatic dysregulation in progressive autonomic failure--a transcranial Doppler sonography monitoring.

Authors:  E Titianova; S Karakaneva; I Velcheva
Journal:  J Neurol Sci       Date:  1997-02-27       Impact factor: 3.181

8.  Comparison of flow and velocity during dynamic autoregulation testing in humans.

Authors:  D W Newell; R Aaslid; A Lam; T S Mayberg; H R Winn
Journal:  Stroke       Date:  1994-04       Impact factor: 7.914

9.  The effect of orthostatic hypotension on cerebral blood flow and middle cerebral artery velocity in autonomic failure, with observations on the action of ephedrine.

Authors:  D J Brooks; S Redmond; C J Mathias; R Bannister; L Symon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

View more
  18 in total

1.  Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Mov Disord Clin Pract       Date:  2017-03-16

Review 2.  The relationship between blood pressure and cognitive function.

Authors:  Vera Novak; Ihab Hajjar
Journal:  Nat Rev Cardiol       Date:  2010-10-26       Impact factor: 32.419

Review 3.  Transcranial Doppler for evaluation of cerebral autoregulation.

Authors:  Ronney B Panerai
Journal:  Clin Auton Res       Date:  2009-04-16       Impact factor: 4.435

4.  Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Semin Neurol       Date:  2020-09-09       Impact factor: 3.420

Review 5.  Transcranial Doppler in autonomic testing: standards and clinical applications.

Authors:  Lucy Norcliffe-Kaufmann; Brahyan Galindo-Mendez; Ana-Lucia Garcia-Guarniz; Estibaliz Villarreal-Vitorica; Vera Novak
Journal:  Clin Auton Res       Date:  2017-08-18       Impact factor: 4.435

6.  The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale.

Authors:  Horacio Kaufmann; Richard Malamut; Lucy Norcliffe-Kaufmann; Kathleen Rosa; Roy Freeman
Journal:  Clin Auton Res       Date:  2011-11-02       Impact factor: 4.435

Review 7.  Orthostatic Hypotension in Parkinson Disease.

Authors:  Jose-Alberto Palma; Horacio Kaufmann
Journal:  Clin Geriatr Med       Date:  2019-09-06       Impact factor: 3.076

8.  Droxidopa in neurogenic orthostatic hypotension.

Authors:  Horacio Kaufmann; Lucy Norcliffe-Kaufmann; Jose-Alberto Palma
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-06-19

Review 9.  Meta-analysis of the safety and efficacy of droxidopa for neurogenic orthostatic hypotension.

Authors:  Ahmed Elgebaly; Bassant Abdelazeim; Omar Mattar; Mohamed Gadelkarim; Rehab Salah; Ahmed Negida
Journal:  Clin Auton Res       Date:  2016-03-07       Impact factor: 4.435

10.  Hypertension increases cerebral 6-18F-fluorodopa-derived radioactivity.

Authors:  David S Goldstein; Courtney Holmes; Latoya Sewell; Irwin J Kopin
Journal:  J Nucl Med       Date:  2009-08-18       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.